More people to access cholesterol-lowering medicine
Source: PHARMAC Pharmac will widen access to rosuvastatin, a medicine used to treat high cholesterol and reduce the risk of heart attack and stroke, following its 2025/26 Annual Tender process. Rosuvastatin tablets will be available without restrictions from 1 October 2026. This means people will no longer need to meet specific eligibility criteria to access…